Incidence of Allergic Drug Eruption due to Cotrimoxazole in HIV-Positive Individuals with CD4 ≤200 Cells/ul

Incidence of Allergic Drug Eruption due to Cotrimoxazole in HIV-Positive Individuals with CD4 ≤200 Cells/ul

Allergic drug eruptions (ADE) remain a challenge in people living with HIV (PLWH), requiring more studies to guide clinical approaches. While cotrimoxazole is widely used as prophylaxis in PLWH, relationship between client characteristics toward the occurrence of cotrimoxazole ADEs is still poorly u...

Full description

Bibliographic Details
Main Authors: Irene Rosali MD, Putu Siska Virgayanti MD, Della Sabrina Marta MD, Emon Winardi Danudirgo MD, Sisca Hadinata MD
Format: Article
Language:English
Published: SAGE Publishing 2023-01-01
Series:Journal of the International Association of Providers of AIDS Care
Online Access:https://doi.org/10.1177/23259582221146946

Internet

https://doi.org/10.1177/23259582221146946

Similar Items